Gene Kim

Nessuna posizione attualmente

48 anni

Health Technology

Consumer Services

Profilo

Gene Kim worked as an Executive Director-Financial Planning & Analysis at Versartis, Inc. from 2013 to 2018.
He then served as a Vice President-Finance at Kaleido Biosciences, Inc. from 2018 to 2020.
Currently, he holds the position of Vice President-Finance at Dyne Therapeutics, Inc. Mr. Kim completed his undergraduate degree at the University of California, Los Angeles.

Precedenti posizioni note di Gene Kim

Società	Posizione	Fine
KALEIDO BIOSCIENCES, INC.	Corporate Officer/Principal	01/01/2020
Versartis, Inc. Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA.	Corporate Officer/Principal	01/05/2018
DYNE THERAPEUTICS, INC.	Director of Finance/CFO	-

Vedi nel dettaglio l'esperienza di Gene Kim

Formazione di Gene Kim

University of California, Los Angeles

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Gene Kim

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
KALEIDO BIOSCIENCES, INC.	Health Technology
DYNE THERAPEUTICS, INC.	Health Technology

Aziende private	1
Versartis, Inc. Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA.	Health Technology